Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo Hiroyuki YoshiokaSeiji HamaKaoru Kurisu OriginalPaper Pages: 197 - 203
Adenovirus Mediated Gene Therapy in a Glioblastoma Vaccine Model; Specific Antitumor Immunity and Abrogation of Immunosuppression Andrew M DonsonNicholas K Foreman OriginalPaper Pages: 205 - 214
Urokinase induces receptor mediated brain tumor cell migration and invasion Tobey J. MacDonaldYves A. DeClerckWalter E. Laug OriginalPaper Pages: 215 - 226
Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1 R.J. BohinskiP.A. BejaranoJ.A. Whitsett OriginalPaper Pages: 227 - 231
Soluble CD95 (Fas/APO-1) in Malignant Glioma: (No) Implications for CD95-based Immunotherapy? Johannes R. StrefferMonika SchusterMichael Weller OriginalPaper Pages: 233 - 235
The Significance of the Expression of Tumor Suppressor Gene DCC in Human Gliomas Kei NakataniNaoki YoshimiNoboru Sakai OriginalPaper Pages: 237 - 242
Alleletyping of an Oligodendrocyte-type-2 Astrocyte Lineage Derive from a Human Glioblastoma Multiforme Xin MaoRita BarfootMark Noble OriginalPaper Pages: 243 - 250
Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma M.F. RoesdiT.J. PostmaJ.J. Heimans OriginalPaper Pages: 251 - 255
Increased proliferative activity due to necroses induced by pre- operative embolization in benign meningiomas Efstratios PatsourisRudolf LaasDimitrios Stavrou OriginalPaper Pages: 257 - 264
Central Nervous System Atypical Teratoid Tumor/Rhabdoid Tumor: Response to Intensive Therapy and Review of the Literature Joanne M. HildenJan WattersonBernd W. Scheithauer OriginalPaper Pages: 265 - 275
The Pathogenesis of Cysts Accompanying Intra-axial Primary and Metastatic Tumors of the Central Nervous System Paul N.M. LohleHans A.L. WurzerK. Gwan Go OriginalPaper Pages: 277 - 285
